» Articles » PMID: 24747741

Is Alzheimer's Disease a Systemic Disease?

Overview
Specialties Biochemistry
Biophysics
Date 2014 Apr 22
PMID 24747741
Citations 111
Authors
Affiliations
Soon will be listed here.
Abstract

Although Alzheimer's disease (AD) is the most common neurodegenerative disease, the etiology of AD is not well understood. In some cases, genetic factors explain AD risk, but a high percentage of late-onset AD is unexplained. The fact that AD is associated with a number of physical and systemic manifestations suggests that AD is a multifactorial disease that affects both the CNS and periphery. Interestingly, a common feature of many systemic processes linked to AD is involvement in energy metabolism. The goals of this review are to 1) explore the evidence that peripheral processes contribute to AD risk, 2) explore ways that AD modulates whole-body changes, and 3) discuss the role of genetics, mitochondria, and vascular mechanisms as underlying factors that could mediate both central and peripheral manifestations of AD. Despite efforts to strictly define AD as a homogeneous CNS disease, there may be no single etiologic pathway leading to the syndrome of AD dementia. Rather, the neurodegenerative process may involve some degree of baseline genetic risk that is modified by external risk factors. Continued research into the diverse but related processes linked to AD risk is necessary for successful development of disease-modifying therapies.

Citing Articles

Amyloid-β and heart failure in Alzheimer's disease: the new vistas.

Al-Kuraishy H, Sulaiman G, Mohammed H, Mohammed S, Al-Gareeb A, Albuhadily A Front Med (Lausanne). 2025; 12:1494101.

PMID: 39967593 PMC: 11832649. DOI: 10.3389/fmed.2025.1494101.


Lipidome disruption in Alzheimer's disease brain: detection, pathological mechanisms, and therapeutic implications.

He S, Xu Z, Han X Mol Neurodegener. 2025; 20(1):11.

PMID: 39871348 PMC: 11773937. DOI: 10.1186/s13024-025-00803-6.


Maresin-like 1 Ameliorates Neuropathology of Alzheimer's Disease in Brains of a Transgenic Mouse Model.

Shrivastava P, Lu Y, Su S, Kobayashi Y, Zhao Y, Lien N Biomedicines. 2025; 12(12.

PMID: 39767773 PMC: 11673747. DOI: 10.3390/biomedicines12122865.


Physical Exercise and Mechanism Related to Alzheimer's Disease: Is Gut-Brain Axis Involved?.

Sanchez-Martinez J, Solis-Urra P, Olivares-Arancibia J, Plaza-Diaz J Brain Sci. 2024; 14(10).

PMID: 39451988 PMC: 11506766. DOI: 10.3390/brainsci14100974.


The reciprocal relationship between amyloid precursor protein and mitochondrial function.

Strope T, Wilkins H J Neurochem. 2024; 168(9):2275-2284.

PMID: 39022868 PMC: 11648070. DOI: 10.1111/jnc.16183.


References
1.
Friedland R, Fritsch T, Smyth K, Koss E, Lerner A, Chen C . Patients with Alzheimer's disease have reduced activities in midlife compared with healthy control-group members. Proc Natl Acad Sci U S A. 2001; 98(6):3440-5. PMC: 30672. DOI: 10.1073/pnas.061002998. View

2.
Xu W, Qiu C, Gatz M, Pedersen N, Johansson B, Fratiglioni L . Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study. Diabetes. 2008; 58(1):71-7. PMC: 2606895. DOI: 10.2337/db08-0586. View

3.
Rita Atti A, Palmer K, Volpato S, Winblad B, De Ronchi D, Fratiglioni L . Late-life body mass index and dementia incidence: nine-year follow-up data from the Kungsholmen Project. J Am Geriatr Soc. 2007; 56(1):111-6. DOI: 10.1111/j.1532-5415.2007.01458.x. View

4.
Albert M, Jones K, Savage C, Berkman L, Seeman T, Blazer D . Predictors of cognitive change in older persons: MacArthur studies of successful aging. Psychol Aging. 1995; 10(4):578-89. DOI: 10.1037//0882-7974.10.4.578. View

5.
Rovio S, Kareholt I, Helkala E, Viitanen M, Winblad B, Tuomilehto J . Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease. Lancet Neurol. 2005; 4(11):705-11. DOI: 10.1016/S1474-4422(05)70198-8. View